Condition research

Parkinson’s disease

Explore selected studies in early and moderate Parkinson’s disease, including drug and gene-therapy research. Eligibility, disease stage and study design differ between trials.

MeSH D010300 · Also indexed as Parkinson Disease

Find a study to explore

11 covered studies · 6 enrolling · 2 with posted results

Coverage grows through automated registry checks for relevant drug and biological treatment studies. This is not every trial or available treatment, and source checks do not establish clinical benefit. Enrollment and results counts exclude records whose source checks are overdue or under review. Listed ages are only part of eligibility; the study team must confirm eligibility and availability at your location.

Showing 1–8 of 11 matching studies · Page 1 of 2

Sorted by the registry’s latest update, not our check date. With the enrolling filter, locations must be marked recruiting; other views include sites that may be closed.

Search all studies on ClinicalTrials.gov

Trials in this coverage

Drug research

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

US: FDA approval not reviewed here

The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.

Phase 2 · Enrolling participants

Planned enrollment: 80 participants

Study ages: 18 Years to 65 Years

Recruiting sites listed in: United States

No results-posting date in this record

Read trial record and results

Checked Oct 27, 2026

Drug research

Prevent Cognitive Decline in GBA-associated Parkinson's Disease

US: FDA approval not reviewed here

The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.

Phase 2 · Enrolling participants

Planned enrollment: 120 participants

Study ages: 35 Years to 80 Years

Recruiting sites listed in: Germany

No results-posting date in this record

Read trial record and results

Checked Oct 27, 2026

Drug research

Recent registry updates

All updates for this condition

Trial updateOct 27, 2026

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy: registry status update

The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.

Original evidence Context and limitations

Trial updateOct 23, 2026

Prevent Cognitive Decline in GBA-associated Parkinson's Disease: registry status update

The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.

Original evidence Context and limitations

Parkinson’s disease

Find a study to explore

Trials in this coverage

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Prevent Cognitive Decline in GBA-associated Parkinson's Disease

Recent registry updates

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy: registry status update

Prevent Cognitive Decline in GBA-associated Parkinson's Disease: registry status update

BHV-8000

Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)

Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

Carbidopa–levodopa extended release

Prasinezumab

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs): registry status update

BHV-8000: registry status update

Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease: registry status update

Carbidopa–levodopa extended release: registry status update